跳至主要内容
临床试验/NCT01874015
NCT01874015Unknown1 期

Transplantation of Bone Marrow Mesenchymal Stem Cell in Moderate to Severe Fistulizing Crohn's Disease

Royan Institute1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2013年2月最近更新:
适应症

试验速览

阶段
1 期
入组人数
10
试验地点
1
主要终点
fistula closure

研究概览

简要总结

This study is a prospective, randomized, parallel, phase 1 trial to assess the safety and feasibility of the transplantation of bone marrow derived mesenchymal stem cells (MSCs) in fistulizing Crohn's disease.

详细描述

In this study all eligible patients were randomly allocated into two study groups by a permuted block randomization method: group A receives only autologous MSCs suspended in fibrin glue, group B receives autologous MSCs+ Fibroblasts. Both groups receive 4 injections inside the wall and lumen of the fistula. Injections will be repeated every month.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 1- Poor response to routine treatments in refractory Crohn's disease with fistula.
  • 2- CDAI>220 3- Age 18 to 60 years 4- GFR>30, Cr<2 5- The presence of perinea fistula.

排除标准

  • pregnancy

结局指标

主要结局

fistula closure

时间窗: 4months

Evaluation the fistula closure after mesenchymal cell transplantation in patients with crohn's disease.

次要结局

  • CDAI(4months)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Transplantation of Bone Marrow Mesenchymal Stem Cell... | 临床试验